HEOR Strategy & Gap Analysis

We can review existing study protocols with a focus on opportunities for inclusion of HEOR supportive data (e.g., inclusion of itemized medical resource utilization (MRU), itemized billing data, necessary follow-up data relevant to MRU and billing such as adverse events and rehospitalizations during and after the index procedure) and maximize your HEOR strategy.

Combining real-world data from a number of sources including disease, device and medication registries; patient reported outcomes; insurance claims; billing claims; electronic health records and more with primary data collection, our experts can demonstrate your technology’s value in terms of clinical and economic outcomes.

Performing a HEOR gap analysis of existing evidence, we can identify missing elements and develop strategic recommendations for success with regulatory bodies, clinicians, facilities, patients, payers and other decision-makers.